CLOs on the Move


 
Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research. We are headquartered in Cambridge UK. Our eight additional sales, production, and distribution offices are located in Asia, UK, and the USA.   Our mission is to help scientists to discover more. Our vision is to be the brand most recommended by life science researchers.   We recognise the importance of providing clear and timely information to our existing and potential ...
  • Number of Employees: 100-250
  • Annual Revenue: $100-250 Million
  • www.abcam.com
  • 1 Kendall Sq
    Cambridge, MA USA 02139
  • Phone: 617.225.2272

Executives

Name Title Contact Details

Similar Companies

Peoria Tazewell Pathology Group

Peoria Tazewell Pathology Group is a Peoria, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Issaquah Dental Laboratory

Issaquah Dental Lab is dedicated to providing a working environment which attracts & retains high quality technicians, staff, and clients. Issaquah Dental Lab's success is defined by an on going commitment to our co-workers, clients, suppliers, and

Health Scan Imaging

Health Scan Imaging is a Palm Desert, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DiaDexus

Diadexus is a diagnostics company developing and commercializing products that aid in the prediction of cardiac disease risk, providing healthcare providers with actionable information for managing patients. We pioneered the testing of Lp-PLA2 (lipoprotein-associated phospholipase A2), a marker of vascular-specific inflammation that provides new information, over and above traditional risk factors measured in a lipid panel, and has over a decade of peer-reviewed literature validating this biomarker`s utility. Our products are the only two FDA-cleared tests to measure Lp-PLA2: The PLAC® Test ELISA Kit first cleared by the FDA in 2003 and The PLAC® Test for Lp-PLA2 Activity cleared in December 2014. Our pipeline of advanced cardiac biomarkers includes biomarkers for heart failure, proADM, proET-1 and proANP. Each marker gives distinct, additive information for healthcare providers over currently available markers. Diadexus also provides services to pharmaceutical partners to address the need to incorporate biomarkers in clinical development. Our portfolio of advanced cardiac biomarkers is available to be paired with novel therapeutics in development for indications where cardiovascular risk information would provide valuable insights. This information can be used by pharmaceutical companies in targeting the appropriate patient population and understanding the potential long-term side effects for their therapeutics, potentially avoiding long-term follow up studies.

Metaclin Research

Metaclin Research is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.